Eiken Chemical Co., Ltd. (TYO:4549)
Japan · Delayed Price · Currency is JPY 2,173.00
-338.00 (-13.46%)
Jul 31, 2026, 2:20 PM JST
Eiken Chemical Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 42,430 | 41,899 | 40,539 | 40,052 | 43,271 | 42,996 | |
Revenue Growth | 2.94% | 3.36% | 1.22% | -7.44% | 0.64% | 11.20% |
Cost of Revenue | 26,279 | 25,723 | 24,027 | 23,328 | 22,765 | 22,423 |
Gross Profit | 16,151 | 16,176 | 16,512 | 16,724 | 20,506 | 20,573 |
Selling, General & Admin | 9,687 | 9,579 | 13,512 | 13,345 | 8,963 | 8,776 |
Research & Development | 3,676 | 3,676 | - | - | 4,065 | 3,408 |
Operating Expenses | 13,363 | 13,255 | 13,512 | 13,345 | 13,049 | 12,184 |
Operating Income | 2,788 | 2,921 | 3,000 | 3,379 | 7,457 | 8,389 |
Interest Expense | -44 | -29 | -17 | -17 | -16 | -29 |
Interest & Investment Income | 24 | 21 | 17 | 12 | 18 | 20 |
Earnings From Equity Investments | -89 | -89 | - | - | - | - |
Currency Exchange Gain (Loss) | 21 | 12 | 1 | 50 | 14 | 32 |
Other Non Operating Income (Expenses) | -32 | 6 | 133 | 143 | 108 | 95 |
EBT Excluding Unusual Items | 2,668 | 2,842 | 3,134 | 3,567 | 7,581 | 8,507 |
Merger & Restructuring Charges | - | - | -250 | - | - | - |
Gain (Loss) on Sale of Investments | 2,004 | 2,004 | 49 | - | 43 | - |
Gain (Loss) on Sale of Assets | -14 | -14 | -6 | -65 | -33 | -26 |
Other Unusual Items | 1 | 1 | 64 | - | 1 | - |
Pretax Income | 4,659 | 4,833 | 2,991 | 3,502 | 7,592 | 8,481 |
Income Tax Expense | 1,106 | 1,125 | 763 | 868 | 1,856 | 2,263 |
Net Income | 3,553 | 3,708 | 2,228 | 2,634 | 5,736 | 6,218 |
Net Income to Common | 3,553 | 3,708 | 2,228 | 2,634 | 5,736 | 6,218 |
Net Income Growth | 51.71% | 66.43% | -15.41% | -54.08% | -7.75% | 23.28% |
Shares Outstanding (Basic) | 33 | 33 | 34 | 37 | 37 | 37 |
Shares Outstanding (Diluted) | 33 | 33 | 35 | 37 | 37 | 37 |
Shares Change | -3.65% | -4.55% | -6.43% | -0.62% | 0.12% | 0.10% |
EPS (Basic) | 107.81 | 112.50 | 64.82 | 71.69 | 155.17 | 168.26 |
EPS (Diluted) | 107.62 | 112.08 | 64.27 | 71.10 | 153.86 | 167.01 |
EPS Growth | 57.48% | 74.39% | -9.61% | -53.79% | -7.87% | 23.16% |
Free Cash Flow | - | -1,711 | 819 | 1,830 | 4,369 | 3,341 |
Free Cash Flow Per Share | - | -51.71 | 23.63 | 49.39 | 117.19 | 89.72 |
Dividend Per Share | 58.000 | 58.000 | 53.000 | 51.000 | 51.000 | 51.000 |
Dividend Growth | 9.43% | 9.43% | 3.92% | 0% | 0% | 24.39% |
Gross Margin | 38.06% | 38.61% | 40.73% | 41.76% | 47.39% | 47.85% |
Operating Margin | 6.57% | 6.97% | 7.40% | 8.44% | 17.23% | 19.51% |
Profit Margin | 8.37% | 8.85% | 5.50% | 6.58% | 13.26% | 14.46% |
Free Cash Flow Margin | - | -4.08% | 2.02% | 4.57% | 10.10% | 7.77% |
EBITDA | 5,387 | 5,457 | 5,286 | 5,705 | 9,582 | 10,447 |
EBITDA Margin | 12.70% | 13.02% | 13.04% | 14.24% | 22.14% | 24.30% |
D&A For EBITDA | 2,599 | 2,536 | 2,286 | 2,326 | 2,125 | 2,058 |
EBIT | 2,788 | 2,921 | 3,000 | 3,379 | 7,457 | 8,389 |
EBIT Margin | 6.57% | 6.97% | 7.40% | 8.44% | 17.23% | 19.51% |
Effective Tax Rate | 23.74% | 23.28% | 25.51% | 24.79% | 24.45% | 26.68% |